Stocks · Korea 244460 KOSDAQ

Olipass

1,651원 +0.00% Market cap 134억 2026-10-07 close
Data as of 2026-10-07 · Linked from 3 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR7.94x
EPS0 KRW
BPS208 KRW
ROE-905.00%
DPS0 KRW

Returns and 52-week range

1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y+0.00%
YTD+0.00%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20219억-251억-257억-2,950.7%
202223억-241억-248억-1,050.9%
Quarterly
2022 3Q2억-51억-52억-2,578.8%
2022 4Q7억-58억-62억-819.6%
2023 1Q9억-51억-54억-570.5%
2023 2Q18억-24억-25억-131.4%
2023 3Q18억-29억-29억-157.0%
2026 1Q91,366,355원-18억-19억-1,958.0%

Company

CEO김태현
Founded2006-11-16
Fiscal year end12
Address: 경기도 용인시 기흥구 동백중앙로16번길 16-4 에이스동백타워1동 20층

Peers in the same sector

CompanyMarket capP/EP/B1M
피플바이오136억—0.43+0.00%
피씨엘168억—2.52+0.00%
엑셀세라퓨틱스179억—2.51-7.59%
엠에프씨224억25.340.70+4.61%
풍전약품225억77.830.57-7.34%
서울제약225억29.750.55-1.07%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.